Describe poliovirus and the other enteroviruses. Compare the two polio vaccines and discuss eradication.
The Enteroviruses
- Picornaviruses — "pico" (small) plus "RNA"; the smallest RNA viruses. naked, icosahedral, with single-stranded positive-sense RNA, so the genome acts directly as messenger RNA
- Being naked they are acid-stable and resistant to bile, detergents and the environment, which is exactly what a virus transmitted by the faecal-oral route through the stomach requires
- Members — poliovirus types 1, 2 and 3; coxsackie A and B; ECHOviruses; newer enteroviruses including EV71; rhinovirus (which is acid-labile and confined to the nose); and hepatitis A virus
| Virus | Diseases |
|---|---|
| Coxsackie A | Herpangina (vesicles on the soft palate with fever); hand, foot and mouth disease (A16 and EV71); aseptic meningitis; acute haemorrhagic conjunctivitis (A24) |
| Coxsackie B | Bornholm disease (epidemic pleurodynia — "devil's grip"); myocarditis and pericarditis, a leading viral cause; aseptic meningitis; neonatal sepsis-like illness |
| ECHOviruses | Aseptic meningitis (the commonest cause), febrile rashes, neonatal infection |
| EV71 | Hand, foot and mouth disease with a notable tendency to brainstem encephalitis and neurogenic pulmonary oedema; major outbreaks in the Asia-Pacific region |
| Rhinovirus | The common cold — over 100 serotypes, which is why immunity is useless and no vaccine is feasible; acid-labile, so it cannot infect the gut, and grows best at 33°C, the temperature of the nose |
Poliovirus — Pathogenesis
Ingestion; the virus is acid-stable and survives the stomach → Primary multiplication in the oropharynx and the lymphoid tissue of the gut — tonsils and PEYER patches → Minor viraemia, which in most people is contained here → In a minority, spread to the reticuloendothelial system and a major viraemia → Invasion of the central nervous system → Selective destruction of the anterior horn cells of the spinal cord, and of brainstem motor nuclei in bulbar disease → asymmetrical flaccid paralysis with NO sensory loss, since only motor neurons are affected
- The outcome is overwhelmingly favourable — about 90 to 95% are asymptomatic, 4 to 8% have a minor non-specific febrile illness, 1 to 2% develop non-paralytic aseptic meningitis, and fewer than 1% develop paralytic disease. But every infected person excretes virus and can infect others
- Provocative factors that increase the risk of paralysis and determine its site — intramuscular injections during the incubation period, strenuous exercise, tonsillectomy (predisposing to bulbar disease), pregnancy and immunodeficiency
- Post-polio syndrome — new weakness developing decades after recovery, from attrition of the surviving enlarged motor units
CLINICAL PEARL
Fewer than one infected person in a hundred is paralysed, and that is what made polio hard to eradicate rather than easy. Because the great majority of infections are silent yet still excrete virus, a single paralytic case implies hundreds already infected, and transmission continues invisibly wherever coverage falls. Surveillance therefore cannot wait for paralysis to be common — it depends on investigating every case of acute flaccid paralysis in a child, whatever the suspected cause.
The Two Vaccines
| Feature | OPV (Sabin) — oral, live attenuated | IPV (Salk) — injectable, killed |
|---|---|---|
| Intestinal (mucosal) immunity | Excellent — induces secretory IgA, so the vaccinated child no longer transmits wild virus | Poor — protects the individual from paralysis but permits gut infection and onward spread |
| Herd immunity | Yes — vaccine virus spreads to contacts and immunises them | NO |
| Administration and cost | Oral drops; needs no needle or trained injector; very cheap — ideal for mass campaigns | Injection; costlier; needs trained staff |
| Safety | Vaccine-associated paralytic poliomyelitis (VAPP) in about 1 in 2.7 million doses; and reversion to vaccine-derived poliovirus (VDPV), which can circulate and cause outbreaks where coverage is poor | Completely safe — no VAPP, no VDPV; can be given to the immunocompromised and their contacts |
| Cold chain | Sensitive; damaged by heat | More stable |
| Current use | Bivalent OPV (types 1 and 3) after type 2 was withdrawn in 2016 following its eradication, because most VDPV outbreaks were type 2 | Introduced into routine schedules worldwide to cover type 2 and to move toward an OPV-free endgame |
Polio Eradication
- INDIA was certified polio-free in 2014, the last case having occurred in West Bengal in January 2011 — an achievement widely thought impossible, given the population, density and sanitation
- How it was done — National Immunisation Days ("pulse polio") delivering OPV to every child under 5 on a single day; mopping-up rounds; social mobilisation to overcome refusal; and above all acute flaccid paralysis (AFP) surveillance, in which every child under 15 with sudden flaccid weakness is investigated with two stool samples
- Wild type 2 was declared eradicated in 2015 and type 3 in 2019; only wild type 1 remains, endemic in Pakistan and Afghanistan
- The remaining obstacles are conflict, inaccessibility, vaccine refusal and circulating vaccine-derived poliovirus, which now causes more cases in some regions than wild virus does
- Why polio was a plausible target — man is the only reservoir, there is no chronic carrier state in the immunocompetent, and effective cheap vaccines exist; the obstacle was silent transmission, not biology
Laboratory Diagnosis of Poliomyelitis
- Stool is the specimen of choice — two samples collected at least 24 hours apart, within 14 days of the onset of paralysis, and transported in a reverse cold chain to a national laboratory
- Virus is excreted in stool for weeks, far longer than it is present in throat secretions, which is why stool rather than a throat swab is used
- Cell culture in human or monkey kidney lines, with typing by neutralisation; and intratypic differentiation by molecular methods to distinguish wild virus from vaccine virus and from vaccine-derived poliovirus — the critical distinction in a certified polio-free country
- Cerebrospinal fluid shows a lymphocytic pleocytosis with normal glucose, but the virus is rarely isolated from it
- Environmental surveillance of sewage detects circulating virus even where no paralytic case has occurred, and is now an important part of the endgame
Applied Aspects
- Investigate every case of acute flaccid paralysis in a child and notify it; the differential includes Guillain-Barré syndrome, transverse myelitis and traumatic neuritis, but surveillance depends on all of them being reported
- Avoid unnecessary intramuscular injections in a febrile child in an endemic setting, because of provocative paralysis — a specific and often forgotten precaution
- Two stool samples 24 hours apart are required for virological investigation of acute flaccid paralysis, collected within 14 days of onset
- Give IPV to immunodeficient children and their household contacts, never OPV, since the live vaccine can cause paralysis and prolonged excretion in them
- Enteroviruses are a leading cause of aseptic meningitis in children, and recognising this avoids prolonged unnecessary antibiotics in a self-limiting illness
- Hand, foot and mouth disease is usually benign, but EV71 outbreaks require vigilance for brainstem encephalitis, which can progress rapidly
- Polio-free does not mean polio-proof; importation remains possible while wild virus circulates anywhere, which is why India maintains immunisation, surveillance and border vaccination posts
- Environmental sewage surveillance detected poliovirus in India after the last clinical case, demonstrating that silent circulation can be found without a paralysed child
- Coxsackie B myocarditis should be considered in a young patient with chest pain and a raised troponin after a viral illness, since it is a leading infectious cause of cardiomyopathy
- The rhinovirus has over 100 serotypes, which is why the common cold recurs indefinitely and why no vaccine is possible — a useful contrast with measles, which has one
- Enteroviruses circulate most in the monsoon and post-monsoon months in India, and cluster in children; recognising a seasonal outbreak of aseptic meningitis prevents a great deal of unnecessary investigation
- Distinguish poliomyelitis from Guillain-Barré syndrome — polio is asymmetrical, febrile at onset, purely motor and without sensory loss, whereas Guillain-Barré is symmetrical, ascending, afebrile and often has sensory features
- Vaccine-derived poliovirus is now the commoner cause of paralytic polio in several regions, which is the argument for moving to IPV once wild virus is gone
- Never give OPV to a child known to be immunodeficient, or to the household contact of one; prolonged excretion and paralysis have both occurred
- Report acute flaccid paralysis within 24 hours and arrange the two stool samples; the target rate of non-polio AFP reporting is itself a measure of how sensitive surveillance is
- Post-polio syndrome affects survivors decades later, and India has a large cohort of people paralysed before eradication who need rehabilitation and orthotic support rather than antiviral treatment
- Hand hygiene and safe water interrupt enterovirus transmission, which is why polio was a disease of poor sanitation and why its eradication required vaccine rather than waiting for sanitation to improve
- Explain to parents why a healthy child needs repeated polio drops; refusal in some communities was a genuine obstacle, and it was overcome by engagement rather than by insistence
- Maintain routine immunisation as well as campaign doses; campaigns raise population immunity quickly but routine coverage is what sustains it
All questions in RNA Viruses & HIV
- Q1Describe influenza virus with its structure, antigenic variation, complications and prevention. ★
- Q2Describe poliovirus and the other enteroviruses. Compare the two polio vaccines and discuss eradication. ★
- Q3Describe HIV with its structure, replication, transmission, natural history and laboratory diagnosis. ★
- Q4Classify the arboviruses. Describe dengue, chikungunya and Japanese encephalitis with vector control. ★
- Q5Describe rabies virus with its pathogenesis, clinical features and post-exposure prophylaxis. ★
- SN1Describe measles with its clinical features, complications and prevention. ★
- SN2Describe rubella and the congenital rubella syndrome with its diagnosis and prevention. ★
- SN3Describe mumps with its clinical features, complications and prevention. ★
- SN4Describe rotavirus and the other viral causes of gastroenteritis with their management. ★
- SN5Describe hepatitis A and hepatitis E with their epidemiology, course and prevention. ★
- SN6Describe hepatitis C with its natural history, diagnosis and treatment. ★
- SN7Describe the coronaviruses and the other emerging viral infections.